Trials & Tribulations An overlooked immune cell population may offer new direction for cell and gene therapy July 11, 2025Vol.51 No.27By Arthur Machlenkin
Sponsored Unraveling connections between diabetes and cancer: Insights from metabolism research at City of Hope July 11, 2025Vol.51 No.27By Charles Brenner
FreeIn the Archives Rick and Mary Pazdur on facing “the other side of the stethoscope”A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology July 11, 2025Vol.51 No.27By Katie Goldberg
She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research July 03, 2025Vol.51 No.26By Jacquelyn Cobb
FreeGuest Editorial As cancer scientists, we must change how we engage with the public on the impact of NIH cutsWhat the scientific method obscures July 03, 2025Vol.51 No.26By George J. Weiner and Elizabeth M. Jaffee
Free In weekly vigils, current and former NIH staff grieve the impact of Trump cutsThe Saturday gatherings at NIH’s Metro station are part graveside service, part street theater July 03, 2025Vol.51 No.26By Claire Marie Porter
Sponsored Scaling excellence: How City of Hope is transforming cancer care delivery July 03, 2025Vol.51 No.26By Alan H. Bryce and Walter M. Stadler
FreeIn the Archives Since 1991, the Women’s Health Initiative has saved lives, cut costs, and fostered team science July 03, 2025Vol.51 No.26
How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest June 27, 2025Vol.51 No.25By Paul Goldberg
Capitol Hill At House hearing, Democrats clash with RFK Jr. over “radical obstruction of congressional oversight,” vaccine policiesRep. Lori Trahan: “People are going to die” June 27, 2025Vol.51 No.25By Claire Marie Porter
